{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T19:00:19Z","timestamp":1781895619582,"version":"3.54.5"},"reference-count":35,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T00:00:00Z","timestamp":1577404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Hematological malignancies are usually systemic diseases of life-threatening impact, and frequently require prompt and energetic therapeutic intervention. Due to systemic involvement, the role of surgery is generally limited to diagnostic approaches, and it is very rarely employed as a therapeutic modality. Splenectomy represents an exception to this paradigm, being used both as a diagnostic and tumor debulking procedure, notably in splenic lymphomas. Materials and Methods: We investigated the role of splenectomy in a single center prospective study of splenectomy outcome in patients with splenic involvement in the course of lymphoproliferative disorders. In the present study, we included all patients treated in our department for lymphoid malignancies over a period of six years, who underwent splenectomy as a diagnostic or debulking procedure after referral and workup, or had been referred to our department after first being splenectomized and diagnosed with splenic lymphoma. Patient characteristics and treatment outcome were investigated. Results: We enrolled 54 patients, with 34 (63%) splenectomized patients: 12 splenectomies (22.2%) for diagnostic purposes and 22 (40.7%) for treatment. Special attention was given to the 28 (51.85%) patients diagnosed with splenic marginal zone lymphoma (SMZL), a subtype with a clear therapeutic indication for splenectomy. Average age of patients was 57.5 (\u00b113.1) years with a higher prevalence of feminine gender (66.67%). Age above 60 years old (p = 0.0295), ECOG (Eastern Cooperative Oncology Group) &gt; 2 (p = 0.0402) and B-signs (p nonsignificant (NS)) were most frequently found in SMZL patients. Anemia, and notably autoimmune anemia, was more frequent in SMZL versus other small-cell lymphomas and also in splenectomized patients, as was leukocytosis and lymphocytosis. Treatment of patients with lymphoproliferative disorders consisted of chemotherapy and\/or splenectomy. Most SMZL patients received chemotherapy as first line treatment (61.5%) and had only partial response (57.7%). Second treatment line was splenectomy in 80% of patients who required treatment, followed by a 60% rate of complete response (CR). Splenectomy offered a higher complete response rate (twice as high than in non-splenectomized, regardless of histology type, p = NS), followed by a survival advantage (Overall Survival (OS)~64 versus 59 months, p = NS). Particularly, SMZL patients had a 4.8 times higher rate of CR than other non-Hodgkin lymphoma (NHL) patients (p = 0.04), a longer progression free survival (73 months vs. 31 months for other small-cell NHLs p = NS) and a 1.5fold lower death rate (p = NS). The procedure was rather safe, with a 38.5% frequency of adverse reactions, mostly minor and manageable. Conclusions: Our data suggest that splenectomy is an effective and safe therapeutic option in patients with lymphoid malignancies and splenic involvement, particularly splenic marginal zone lymphoma.<\/jats:p>","DOI":"10.3390\/medicina56010012","type":"journal-article","created":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T11:42:47Z","timestamp":1577446967000},"page":"12","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Splenectomy in Lymphoproliferative Disorders: A Single Eastern European Center Experience"],"prefix":"10.3390","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7272-4513","authenticated-orcid":false,"given":"Minodora","family":"Onis\u00e2i","sequence":"first","affiliation":[{"name":"Faculty of General Medicine, University of Medicine and Pharmacy Carol Davila Bucharest, 050474 Bucharest, Romania"},{"name":"Hematology Department, Emergency University Hospital Bucharest, 050098 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana-Maria","family":"Vl\u0103d\u0103reanu","sequence":"additional","affiliation":[{"name":"Faculty of General Medicine, University of Medicine and Pharmacy Carol Davila Bucharest, 050474 Bucharest, Romania"},{"name":"Hematology Department, Emergency University Hospital Bucharest, 050098 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Nica","sequence":"additional","affiliation":[{"name":"Faculty of General Medicine, University of Medicine and Pharmacy Carol Davila Bucharest, 050474 Bucharest, Romania"},{"name":"Intensive Care Unit, Emergency University Hospital Bucharest, 050098 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea","family":"Sp\u00eenu","sequence":"additional","affiliation":[{"name":"Faculty of General Medicine, University of Medicine and Pharmacy Carol Davila Bucharest, 050474 Bucharest, Romania"},{"name":"Hematology Department, Emergency University Hospital Bucharest, 050098 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"G\u0103man","sequence":"additional","affiliation":[{"name":"Faculty of General Medicine, University of Medicine and Pharmacy Carol Davila Bucharest, 050474 Bucharest, Romania"},{"name":"Hematology Department, Emergency University Hospital Bucharest, 050098 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horia","family":"Bumbea","sequence":"additional","affiliation":[{"name":"Faculty of General Medicine, University of Medicine and Pharmacy Carol Davila Bucharest, 050474 Bucharest, Romania"},{"name":"Hematology Department, Emergency University Hospital Bucharest, 050098 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Voican","sequence":"additional","affiliation":[{"name":"Hematology Department, Emergency University Hospital Bucharest, 050098 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iuliana","family":"Iordan","sequence":"additional","affiliation":[{"name":"Hematology Department, Emergency University Hospital Bucharest, 050098 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Alexandru","sequence":"additional","affiliation":[{"name":"Faculty of General Medicine, University of Medicine and Pharmacy Carol Davila Bucharest, 050474 Bucharest, Romania"},{"name":"Plastic Reconstructive Surgery Department, Emergency University Hospital Bucharest, 050098 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihnea","family":"Zdrenghea","sequence":"additional","affiliation":[{"name":"Department of Hematology, Ion Chiricuta Oncology Institute, Iuliu Hatieganu University of Medicine and Pharmacy, 400015 Cluj Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Gheorghita","sequence":"additional","affiliation":[{"name":"Faculty of Materials Science and Engineering, Politehnica University of Bucharest, 060042 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Gr\u0103dinaru","sequence":"additional","affiliation":[{"name":"Faculty of General Medicine, University of Medicine and Pharmacy Carol Davila Bucharest, 050474 Bucharest, Romania"},{"name":"4th Surgery Department, Emergency University Hospital Bucharest, 050098 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,12,27]]},"reference":[{"key":"ref_1","first-page":"414","article-title":"Abdominal compartment syndrome\u2014a major complication of large incisional hernia surgery","volume":"108","author":"Mavrodin","year":"2013","journal-title":"Chirurgia"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e6687","DOI":"10.1097\/MD.0000000000006687","article-title":"Adverse local tissue reaction after 2 revision hip replacements for ceramic liner fracture: A case report","volume":"96","author":"Antoniac","year":"2017","journal-title":"Medicine"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.37358\/RC.17.8.5782","article-title":"Effect of the Sterilization Procedures of Different Surgical Meshes for Abdominal Surgery","volume":"68","author":"Earar","year":"2017","journal-title":"Rev. Chim."},{"key":"ref_4","first-page":"443","article-title":"Gastric stromal tumors-Clinical and histopathological analysis of four cases","volume":"98","author":"Neagu","year":"2003","journal-title":"Chirurgia"},{"key":"ref_5","first-page":"657","article-title":"Clinical case-voluminous diaphragmatic hernia-surgically acute abdomen: diagnostic and therapeutical challenges","volume":"106","author":"Dumitrescu","year":"2011","journal-title":"Chirurgia"},{"key":"ref_6","first-page":"567","article-title":"The interdisciplinary approach of an aggressive giant cell tumor of bone complicated with a fracture of the distal femur","volume":"57","author":"Vilcioiu","year":"2016","journal-title":"Rom. J. Morphol. Embryo."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Moldovan, H., Popescu, D., Buliga, T., Filip, A., Antoniac, I., Gheorghita, D., and Molnar, A. (2019). Gastric Adenocarcinoma Associated with Acute Endocarditis of the Aortic Valve and Coronary Artery Disease in a 61-Year-Old Male with Multiple Comorbidities-Combined Surgical Management-Case Report. Medicina (Lithuania), 55.","DOI":"10.3390\/medicina55060242"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1182\/blood.V100.5.1648.h81702001648_1648_1654","article-title":"Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients","volume":"100","author":"Mollejo","year":"2002","journal-title":"Blood"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.leukres.2016.03.005","article-title":"Splenic marginal zone lymphoma: Prognostic factors, role of watch and wait policy, and other therapeutic approaches in the rituximab era","volume":"44","author":"Perrone","year":"2016","journal-title":"Leuk. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/cncr.27773","article-title":"Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database","volume":"119","author":"Olszewski","year":"2013","journal-title":"Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/2040620712453595","article-title":"Marginal zone lymphoma: old, new, targeted, and epigenetic therapies","volume":"3","author":"Joshi","year":"2012","journal-title":"Therap. Adv. Hematol. Oct."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1182\/blood-2002-07-2216","article-title":"Splenic marginal zone lymphoma","volume":"101","author":"Franco","year":"2003","journal-title":"Blood"},{"key":"ref_14","unstructured":"(2017, September 01). National Comprehensive Cancer Network. Available online: https:\/\/www.nccn.org\/store\/login\/login.aspx?ReturnURL=https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/b-cell.pdf."},{"key":"ref_15","first-page":"431","article-title":"Splenectomy in hematology: Current practice and new perspectives","volume":"84","author":"Baccarani","year":"1999","journal-title":"Haematologica"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1470-2045(03)00981-1","article-title":"Splenic marginal-zone lymphoma: a distinct clinical and pathological entity","volume":"4","author":"Thieblemont","year":"2003","journal-title":"Lancet Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/bjh.12011","article-title":"Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: development and validation on 593 cases","volume":"159","author":"Abraira","year":"2012","journal-title":"Br. J. Haematol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1046\/j.1365-2141.2003.04165.x","article-title":"Prognostic features of splenic lymphoma with villous lymphocytes: a report on 129 patients","volume":"120","author":"Matutes","year":"2003","journal-title":"Br. J. Haematol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1002\/cncr.20596","article-title":"Splenic marginal zone lymphoma with or without villous lymphocytes. Hematologic findings and outcomes in a series of 57 patients","volume":"101","author":"Iannitto","year":"2004","journal-title":"Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Thieblemont, C. (2005). Clinical presentation and management of marginal zone lymphomas. Hematol. Am. Soc. Hematol. Educ. Program, 307\u2013313.","DOI":"10.1182\/asheducation-2005.1.307"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/00000478-199605000-00008","article-title":"Splenic marginal zone lymphoma: A distinct B-cell neoplasm","volume":"20","author":"Hammer","year":"1996","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1365-2559.1995.tb00021.x","article-title":"Low-grade B-cell lymphomas of the splenic marginal zone: A clinicopathological and immunohistochemical study of 14 cases","volume":"27","author":"Pawade","year":"1995","journal-title":"Histopathology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMoa013376","article-title":"Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection","volume":"11","author":"Hermine","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1182\/blood-2004-05-1711","article-title":"Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity?","volume":"105","author":"Saadoun","year":"2005","journal-title":"Blood"},{"key":"ref_25","unstructured":"Greer, J., Foerster, J., Lukens, J., Rodgers, G., Paraskevas, F., and Glader, B. (2009). Thrombocytopenia: Pathophysiology and classification. Wintrobe\u2019s Clinical Haematology, Lippincott Williams & Wilkins. [12th ed.]."},{"key":"ref_26","first-page":"80","article-title":"Marginal zone-related neoplasms of splenic and nodal origin","volume":"88","author":"Arcaini","year":"2003","journal-title":"J. Hematol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1097\/00000478-200012000-00001","article-title":"Splenic marginal zone lymphoma with or without plasmacytic differentiation","volume":"24","author":"Molina","year":"2000","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/(SICI)1096-8652(199711)56:3<173::AID-AJH7>3.0.CO;2-V","article-title":"Immunological abnormalities in splenic marginal zone cell lymphoma","volume":"56","author":"Murakami","year":"1997","journal-title":"Am. J. Hematol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.1002\/ajh.23767","article-title":"Characteristics and outcome of warm autoimmune hemolytic anemia in adults: New insights based on a singlecenter experience with 60 patients","volume":"89","author":"Roumier","year":"2014","journal-title":"Am. J. Hematol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.3109\/10428194.2013.861067","article-title":"Long-term follow-up analysis of 100 patients with splenic marginal zone lymphoma treated with splenectomy as first-line treatment","volume":"55","author":"Lenglet","year":"2014","journal-title":"Leuk. Lymphoma."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1182\/blood-2010-09-271437","article-title":"How I diagnose and treat splenic lymphomas","volume":"117","author":"Iannitto","year":"2011","journal-title":"Blood"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/bjh.13320","article-title":"Outcomes in splenic marginal zone lymphoma: analysis of 107 patients treated in British Columbia","volume":"169","author":"Xing","year":"2015","journal-title":"Br. J. Haematol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/archsurg.141.8.755","article-title":"Trends in laparoscopic splenectomy for massive splenomegaly","volume":"141","author":"Grahn","year":"2006","journal-title":"Arch. Surg."},{"key":"ref_34","unstructured":"Klingersmith, M.E. (2008). The Washington Manual of Surgery, Lippincott Williams & Wilkins."},{"key":"ref_35","first-page":"23","article-title":"The implications for patients undergoing splenectomy: postsurgery risk management","volume":"2011","author":"Romano","year":"2011","journal-title":"Dovepress"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/56\/1\/12\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:46:09Z","timestamp":1760190369000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/56\/1\/12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,27]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1]]}},"alternative-id":["medicina56010012"],"URL":"https:\/\/doi.org\/10.3390\/medicina56010012","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,27]]}}}